American International Group’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,738
| Closed | -$185K | – | 2387 |
|
|
2024
Q1 | $185K | Buy |
13,738
+27
| +0.2% | +$365 | ﹤0.01% | 2188 |
|
|
2023
Q4 | $72.1K | Sell |
13,711
-56
| -0.4% | -$295 | ﹤0.01% | 2713 |
|
|
2023
Q3 | $54.2K | Buy |
13,767
+490
| +4% | +$1.93K | ﹤0.01% | 2795 |
|
|
2023
Q2 | $141K | Buy |
13,277
+2,444
| +23% | +$26K | ﹤0.01% | 2365 |
|
|
2023
Q1 | $90.2K | Buy |
10,833
+216
| +2% | +$1.8K | ﹤0.01% | 2507 |
|
|
2022
Q4 | $98K | Sell |
10,617
-39
| -0.4% | -$360 | ﹤0.01% | 2525 |
|
|
2022
Q3 | $137K | Buy |
10,656
+150
| +1% | +$1.93K | ﹤0.01% | 2381 |
|
|
2022
Q2 | $139K | Buy |
10,506
+1,029
| +11% | +$13.6K | ﹤0.01% | 2404 |
|
|
2022
Q1 | $199K | Sell |
9,477
-667
| -7% | -$14K | ﹤0.01% | 2241 |
|
|
2021
Q4 | $243K | Sell |
10,144
-304
| -3% | -$7.28K | ﹤0.01% | 2257 |
|
|
2021
Q3 | $266K | Sell |
10,448
-248
| -2% | -$6.31K | ﹤0.01% | 2253 |
|
|
2021
Q2 | $360 | Buy |
10,696
+2,790
| +35% | +$94 | ﹤0.01% | 2135 |
|
|
2021
Q1 | $307 | Buy |
7,906
+694
| +10% | +$27 | ﹤0.01% | 2121 |
|
|
2020
Q4 | $447 | Sell |
7,212
-93
| -1% | -$6 | ﹤0.01% | 1820 |
|
|
2020
Q3 | $245K | Sell |
7,305
-166
| -2% | -$5.57K | ﹤0.01% | 2015 |
|
|
2020
Q2 | $178K | Sell |
7,471
-2,598
| -26% | -$61.9K | ﹤0.01% | 2192 |
|
|
2020
Q1 | $231K | Buy |
10,069
+4,337
| +76% | +$99.5K | ﹤0.01% | 1831 |
|
|
2019
Q4 | $162K | Sell |
5,732
-48
| -0.8% | -$1.36K | ﹤0.01% | 2339 |
|
|
2019
Q3 | $124K | Buy |
+5,780
| New | +$124K | ﹤0.01% | 2475 |
|